PB
Per Bork Eppers
About Per Bork Eppers
Data last updated:
Per Bork Eppers is an Additional Director at Xellia Pharmaceuticals Private Limited (since 2026). The company operates in Business Services. Xellia Pharmaceuticals Private Limited reported revenue of ₹28.32 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 12 Jan 2026 | ₹28.32 Cr (FY 2025) | Active |
Board colleagues of Per Bork Eppers
| Name | DIN | Company | Designation |
|---|---|---|---|
| Eva Blem | 11469480 | Xellia Pharmaceuticals Private Limited | Additional Director |
| Kasi Visweswara Venkata Satya Lakshmi Nagakishore Sripada | 11416360 | Xellia Pharmaceuticals Private Limited | Additional Director |
| Soren Hostrup | 10724148 | Xellia Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Per Bork Eppers
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Per Bork Eppers
Per Bork Eppers currently holds 1 directorship: Xellia Pharmaceuticals Private Limited (Additional Director, since 12 Jan 2026, revenue ₹28.32 Cr (FY 2025)).
Per Bork Eppers was first appointed on 12 Jan 2026 as Additional Director at Xellia Pharmaceuticals Private Limited.
The current boards of Per Bork Eppers's companies include Eva Blem (Xellia Pharmaceuticals Private Limited), Kasi Visweswara Venkata Satya Lakshmi Nagakishore Sripada (Xellia Pharmaceuticals Private Limited), Soren Hostrup (Xellia Pharmaceuticals Private Limited).